Close Menu

NEW YORK (GenomeWeb) – Veracyte has filed with the US Securities and Exchange Commission for a proposed public offering of 5 million shares of its common stock, the firm said after the close of the market on Wednesday.

The genomic testing company also expects to grant the underwriters a 30-day option to purchase up to 750,000 additional shares at the public offering price.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Sponsored by

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.